This article highlights the ongoing debate on the ethics and accessibility of cell and gene therapies, particularly for treating rare diseases. While these therapies can offer lifesaving benefits, many patients lack access due to factors like cost and distribution. The industry grapples with ethical dilemmas such as how to balance innovation and accessibility, and how to democratize access to critical treatments.
News – Kansas healthcare provider Sunflower Medical Group reports major data breach – TEISS
Kansas-based healthcare provider, Sunflower Medical Group, has reported a major data breach.
